KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:CBLI
Delisted

Cleveland BioLabs Stock Price (Quote)

$0.240
+0.0060 (+2.56%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.202 $0.499 Friday, 27th May 2022 CBLI stock ended at $0.240. This is 2.56% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 8.70% from a day low at $0.230 to a day high of $0.250.
90 days $0.202 $1.06
52 weeks $0.202 $7.10

Historical Cleveland BioLabs prices

Date Open High Low Close Volume
Aug 19, 2019 $1.42 $1.51 $1.42 $1.42 10 366
Aug 16, 2019 $1.41 $1.43 $1.41 $1.41 4 438
Aug 15, 2019 $1.42 $1.42 $1.42 $1.42 204
Aug 14, 2019 $1.43 $1.43 $1.43 $1.43 905
Aug 13, 2019 $1.42 $1.44 $1.42 $1.42 1 910
Aug 12, 2019 $1.44 $1.44 $1.41 $1.42 1 820
Aug 09, 2019 $1.41 $1.42 $1.41 $1.41 1 864
Aug 08, 2019 $1.41 $1.42 $1.41 $1.41 3 085
Aug 07, 2019 $1.43 $1.43 $1.41 $1.42 15 617
Aug 06, 2019 $1.43 $1.44 $1.42 $1.43 5 027
Aug 05, 2019 $1.47 $1.47 $1.42 $1.44 3 009
Aug 02, 2019 $1.42 $1.50 $1.42 $1.44 4 153
Aug 01, 2019 $1.45 $1.49 $1.43 $1.45 1 727
Jul 31, 2019 $1.60 $1.60 $1.51 $1.57 5 057
Jul 30, 2019 $1.60 $1.60 $1.50 $1.50 1 277
Jul 29, 2019 $1.60 $1.60 $1.41 $1.41 16 041
Jul 26, 2019 $1.45 $1.50 $1.45 $1.46 3 828
Jul 25, 2019 $1.48 $1.48 $1.47 $1.47 3 814
Jul 24, 2019 $1.48 $1.48 $1.48 $1.48 79
Jul 23, 2019 $1.46 $1.48 $1.45 $1.48 2 539
Jul 22, 2019 $1.45 $1.49 $1.45 $1.46 3 625
Jul 19, 2019 $1.49 $1.49 $1.49 $1.49 205
Jul 18, 2019 $1.53 $1.53 $1.46 $1.47 1 639
Jul 17, 2019 $1.49 $1.51 $1.45 $1.51 1 668
Jul 16, 2019 $1.50 $1.51 $1.47 $1.49 1 158
Click to get the best stock tips daily for free!

About Cleveland BioLabs

Cleveland BioLabs Cleveland BioLabs, Inc., a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with unmet medical need. Its lead drug candidate includes Entolimod, a Toll-like receptor 5 (TLR5) agonist, which is used for the prevention of death from acute radiation syndrome, and is used as an oncology drug. The company is also developing CBLB612, a pharmacologically optimized synthetic molecule that structurally mimics n... CBLI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT